Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.17 0.00 (-0.42%)
As of: Oct 21, 2026 · 3:30 PM EDT

Chemomab Therapeutics (CMMB) EBT (2011 - 2026)

Updated

Chemomab Therapeutics (CMMB) posted EBT of $2.17 million for Q2 2026, up 5.3% from $2.06 million a year earlier and up 22.1% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) EBT (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBT at Chemomab Therapeutics was $7.55 million, down 36.1% year-over-year; for FY2025, it was $9 million, down 35.5% from FY2024.

  • Annual EBT has declined for three consecutive years, with a four-year compound annual growth rate of -7.9% (FY2021 to FY2025).
  • In prior years, Chemomab Therapeutics' EBT was $13.95 million in FY2024 (-42.4%), $24.22 million in FY2023 (-14.0%), $28.18 million in FY2022 (+125.8%) and $12.48 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly EBT since Q1 2025.
  • On a year-over-year basis, EBT increased in 1 of the last eight quarters, with an average decline of 26.8%.
  • The strongest year-over-year quarter for EBT in the past five years was Q2 2023, with growth of 17.8%; the weakest was Q4 2023, with a decline of 58.6%.
  • According to Business Quant data, EBT for the three prior quarters was $1.77 million (Q1 2026), $1.87 million (Q4 2025) and $1.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 4.28 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.80 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -10.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -653.00 Mn
10 Chemomab Therapeutics 7.49 Mn -27.66 Mn - -2.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.17 Mn
Mar 31, 2026 1.77 Mn
Dec 31, 2025 -16.12 Mn
Sep 30, 2025 1.74 Mn
Jun 30, 2025 -2.06 Mn
Mar 31, 2025 3.32 Mn
Dec 31, 2024 -24.93 Mn
Sep 30, 2024 3.48 Mn
Jun 30, 2024 -3.63 Mn
Mar 31, 2024 3.87 Mn
Dec 31, 2023 3.42 Mn
Sep 30, 2023 4.14 Mn
Jun 30, 2023 -7.94 Mn
Mar 31, 2023 -8.73 Mn
Dec 31, 2022 -8.26 Mn
Sep 30, 2022 -8.08 Mn
Jun 30, 2022 -6.73 Mn
Mar 31, 2022 -5.10 Mn
Dec 31, 2021 -5.04 Mn
Sep 30, 2021 -2.97 Mn
API Access

Chemomab Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=CMMB&period=max&api_key=YOUR_API_KEY